Replimune Group, Inc. — Director's Dealing 2024

Sep 6, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2024-09-04

Reporting Person: Balachandran Madhavan (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-09-04	Employee Stock Option (right to buy)	$10.44	A	64000	Acquired	2034-09-04	Common Stock (64000)	Direct

Footnotes

F1: 25% of the shares underlying this stock option vest on September 4, 2025, and the remainder of the shares underlying this stock option vest in 24 approximately equal monthly installments thereafter.